- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02678494
Brain-Train Home Based Pain Treatment
Home Based Brain-Train Treatment of Central Neuropathic Pain Following Spinal Cord Injury
Study Overview
Detailed Description
Spinal Cord Injury (SCI) affects a person's ability to move and feel sensation from the body. SCI is also an indirect cause of a persistent pain, called Central Neuropathic Pain (CNP). This pain typically develops several months after the injury.
In 30% to 40% of SCI patients, severe CNP affects their everyday living including sleep and mood. Medical treatment of CNP is moderately effective and costly, both to the patient and to the health care system.
In a previous study, some characteristic 'signatures' of brain waves that are related to CNP were defined. Based on this, a novel treatment for CNP based on neurofeedback was developed and clinically tested on five SCI patients. Electroencephalograph (EEG) was used to record patients' brain waves and shown to patients on a computer screen in a simple graphical form (e.g. bars). Patients were trained to change their brain activity at will and, as a consequence, their pain was reduced. Costly laboratory devices were used and once the study was over, an adequate alternative could not be offered to patients.
In this study, a cheap, portable, wireless and user friendly, Conformité Européenne (CE) marked EEG device will be used to train 10 patients to self-administer the therapy in the comfort of their homes. Participants will be given initial training to use the equipment then will be asked to use the system at home for 3 months - initially, 3-5 times a week then, if/when pain subsides, at least once a week or as required.
The primary purpose of the study is to determine whether a portable system for neuromodulation is a useful tool for administering therapy for pain (intensity of pain will be measured by the visual numerical scale (VNS)).
The secondary purpose of the study is a quantitative analysis of changes in the brain activity due to therapy, as measured by EEG; patients' perspective of the home based neuro-therapy (assessed by questionnaires and one-to-one, semi-structured interviews).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glasgow, United Kingdom
- Queen Elizabeth National Spinal Injuries Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- normal or corrected to normal vision
- no history of brain disease or injury
- incomplete/complete injury at level C5 to T12
- central neuropathic pain (below the level of injury)
- intensity of pain 4 or above (VNS)
- stable medication regime (expected not to change during the period of the study), responding to some extent to CNP medication treatment
- patient or caregiver minimum computer literacy (owning a computer, laptop, tablet, ipad etc)
Exclusion Criteria:
- chronic or acute muscular or visceral pain larger than 4 VNS
- epilepsy
- diagnosed mental health problems
- active intervention of pain team (changing existing treatments)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neurofeedback training
Neurofeedback training: self-administered at home for 3 months.
3-5 sessions per week initially, then at least once a week.
Each session consists of 5-6 blocks of 5 minute training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: Baseline and 3 months
|
Change in intensity of pain as measured by the Visual Numerical Scale
|
Baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain activity
Time Frame: Baseline and 3 months
|
Change in brain activity as measured by EEG
|
Baseline and 3 months
|
|
Patients' perspective of home-based neuro-therapy training
Time Frame: 3 months
|
Qualitative assessment of patient's perspective of treatment as assessed by questionnaire and one-to-one semi-structured interview
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aleksandra Vuckovic, Dipl Ing MSc PhD, University of Glasgow
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GN15NE124
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuropathic Pain
-
Unity Health TorontoRecruitingChronic Neuropathic PainCanada
-
University Hospital, Clermont-FerrandFondation ApicilCompletedNeuropathic Traumatic Pain | Pain NRS ≥ 4 | Peripheral Neuropathic Pain | Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4France
-
Pontificia Universidad Catolica de ChileNot yet recruiting
-
Poitiers University HospitalRecruitingChronic Neuropathic PainFrance
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPostherpetic Neuralgia (PHN) | Chemotherapy Induced Neuropathic Pain | Diabetic Peripheral Neuropathic Pain (DPN) | HIV-related Neuropathic Pain (HIV)Colombia, Mexico, Ecuador, Peru, Venezuela
-
Eli Lilly and CompanyRecruitingDiabetic Peripheral Neuropathic PainUnited States, Puerto Rico
-
Shandong Suncadia Medicine Co., Ltd.RecruitingDiabetic Peripheral Neuropathic PainChina
-
Shanghai Yidian Pharmaceutical Technology Development...Not yet recruitingDiabetic Peripheral Neuropathic Pain
-
Ente Ospedaliero Ospedali GallieraCompletedNeuropathic Pain in CancerItaly
-
University Hospital, Strasbourg, FranceTerminatedPostthoracotomy Pain | Postthoracoscopy Neuropathic PainFrance
Clinical Trials on Neurofeedback training
-
University of HartfordCompleted
-
Chang Gung Memorial HospitalWithdrawnPost Operative Pain | Pain, Shoulder
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentUnknown
-
Leiden University Medical CenterCompletedElevated EEG Theta/Beta Ratio
-
Quietmind FoundationCompleted
-
Stanford UniversityCompleted
-
University of FloridaNational Institute on Aging (NIA)RecruitingCognitive Change | Aging | Neurocognitive Disorders, MildUnited States
-
East Kent Hospitals University NHS Foundation TrustExsurgo LtdCompleted
-
Frank ScharnowskiUnknown